Infant formula containing galacto-And fructo-oligosaccharides and Bifidobacterium breve M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study

Journal of Nutritional Science

Volumn 5, Issue , 2016, Pages

  Abrahamse Berkeveld, M ^a   Alles, M ^a   Franke Beckmann, E ^b   Helm, K ^b   Knecht, R ^b   Kollges R ^b   Sandner, B ^b   Knol, J ^c   Ben Amor, K ^a   Bufe, A ^b,d  

^a DANONE NUTRICIA RESEARCH   (Netherlands)

^b NETSTAP EV   (Germany)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Bifidobacterium breve M 16V; Hydrolysed formula; Infant growth; Randomised controlled trials; Synbiotics

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; LACTIC ACID; PLACEBO; PREBIOTIC AGENT; SHORT CHAIN FATTY ACID; SYNBIOTIC AGENT;

ANTHROPOMETRY; ARTICLE; ARTIFICIAL MILK; ATOPIC DERMATITIS; BACTERIAL STRAIN; BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; BODY SIZE; CHILD GROWTH; CLOSTRIDIUM; CLOSTRIDIUM HISTOLYTICUM; CLOSTRIDIUM LITUSEBURENSE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FOOD INTAKE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN EXPERIMENT; INFANT; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; KIDNEY FUNCTION; LIVER FUNCTION; LONGITUDINAL STUDY; MALE; MULTICENTER STUDY; NORMAL HUMAN; NUTRITIONAL TOLERANCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; TREATMENT DURATION; WEIGHT GAIN;

EID: 84992755776     PISSN: 20486790     EISSN: None     Source Type: Journal    
DOI: 10.1017/jns.2016.35     Document Type: Article

References (45)

1. Field CJ (2005) The immunological components of human milk and their effect on immune development in infants. J Nutr 135, 1-4.
2. Garcia C, Duan RD, Brevaut-Malaty V, et al. (2013) Bioactive compounds in human milk and intestinal health and maturity in preterm newborn: An overview. Cell Mol Biol (Noisy-le-grand) 59, 108-131.
3. Jost T, Lacroix C, Braegger C, et al. (2015) Impact of human milk bacteria and oligosaccharides on neonatal gut microbiota establishment and gut health. Nutr Rev 73, 426-437.
4. Greer FR, Sicherer SH, Burks AW, et al. (2008) Effects of early nutritional interventions on the development of atopic disease in infants and children: The role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 121, 183-191.
5. Koletzko S, Niggemann B, Arato A, et al. (2012) Diagnostic approach and management of cows-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr 55, 221-229.
6. Wopereis H, Oozeer R, Knipping K, et al. (2014) The first thousand days-intestinal microbiology of early life: establishing a symbiosis. Pediatr Allergy Immunol 25, 428-438.
7. Bjorksten B, Sepp E, Julge K, et al. (2001) Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108, 516-520.
8. Gibson GR & Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 1401-1412.
9. Osborn DA & Sinn JK (2013) Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev 3, CD006474.
10. Vandenplas Y, Zakharova I & Dmitrieva Y (2015) Oligosaccharides in infant formula: more evidence to validate the role of prebiotics. Br J Nutr 113, 1339-1344.
11. Moro G, Arslanoglu S, Stahl B, et al. (2006) A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 91, 814-819.
12. Knol J, Boehm G, Lidestri M, et al. (2005) Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatr Suppl 94, 31-33.
13. Costalos C, Kapiki A, Apostolou M, et al. (2008) The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev 84, 45-49.
14. Arslanoglu S, Moro GE, Schmitt J, et al. (2008) Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 138, 1091-1095.
15. Bruzzese E, Volpicelli M, Squeglia V, et al. (2009) A formula containing galacto-And fructo-oligosaccharides prevents intestinal and extra-intestinal infections: An observational study. Clin Nutr 28, 156-161.
16. Arslanoglu S, Moro GE, Boehm G, et al. (2012) Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost 26, 49-59.
17. Hougee S, Vriesema AJ, Wijering SC, et al. (2010) Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: A bacterial strain comparative study. Int Arch Allergy Immunol 151, 107-117.
18. van der Aa LB, Heymans HS, van Aalderen WM, et al. (2010) Effect of a new synbiotic mixture on atopic dermatitis in infants: A randomized-controlled trial. Clin Exp Allergy 40, 795-804.
19. van der Aa LB, van Aalderen WM, Heymans HS, et al. (2011) Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy 66, 170-177.
20. Verwimp JJ, Bindels JG, Barents M, et al. (1995) Symptomatology and growth in infants with cows milk protein intolerance using two different whey-protein hydrolysate based formulas in a Primary Health Care setting. Eur J Clin Nutr 49, Suppl. 1, S39-S48.
21. Giampietro PG, Kjellman NI, Oldaeus G, et al. (2001) Hypoallergenicity of an extensively hydrolyzed whey formula. Pediatr Allergy Immunol 12, 83-86.
22. Koletzko B, Shamir R, Ashwell M, et al. (2012) Quality and safety aspects of infant nutrition. Ann Nutr Metab 60, 179-184.
23. Hernell O (2012) Current safety standards in infant nutrition-A European perspective. Ann Nutr Metab 60, 188-191.
24. American Academy of Pediatrics, Taskforce on Clinical Testing of Infant Formulas (1988) Clinical Testing of Infant Formulas with Respect to Nutritional Suitability for Term Infants. Report Prepared Under FDA Contract 223-86-2117. http://www.fda. gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatory Information/InfantFormula/ucm170649.htm
25. Frank C (2004) Säuglingsernährung. Mainz: Kirchheim-Verlag.
26. Hanifin JM & Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Dermatovener S92, 44-47.
27. Likert R (1932) A technique for the measurement of attitudes. Arch Psychol 140, 1-55.
28. European Task Force on Atopic Dermatitis (1993) Severity scoring of atopic dermatitis: The SCORAD index. Consensus report of the European task force on atopic dermatitis. Dermatology 186, 23-31.
29. Knol J, Haarman M, Kafka C, et al. (2004) P0030 PP quantitative real time PCR of bifidobacterial species of infants receiving a prebiotic infant formula. J Pediatr Gastroenterol Nutr 39, S67-S68.
30. Zoetendal EG, Ben-Amor K, Harmsen HJ, et al. (2002) Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-Targeted probes. Appl Environ Microbiol 68, 4225-4232.
31. Knol J, Scholtens P, Kafka C, et al. (2005) Colon microflora in infants fed formula with galacto-And fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 40, 36-42.
32. Koletzko B, Ashwell M, Beck B, et al. (2002) Characterisation of infant food modifications in the European Union. Ann Nutr Metab 46, 231-242.
33. WHO Multicentre Growth Reference Study Group (2006) WHO Child Growth Standards Length/Height-for-Age, Weight-for-Age, Weightfor-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development, p. 312. Geneva: World Health Organization.
34. Puccio G, Cajozzo C, Meli F, et al. (2007) Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics. Nutrition 23, 1-8.
35. Vlieger AM, Robroch A, van Buuren S, et al. (2009) Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: A randomised controlled trial. Br J Nutr 102, 869-875.
36. Chouraqui JP, Grathwohl D, Labaune JM, et al. (2008) Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. Am J Clin Nutr 87, 1365-1373.
37. Mugambi MN, Musekiwa A, Lombard M, et al. (2012) Synbiotics, probiotics or prebiotics in infant formula for full term infants: A systematic review. Nutr J 11, 81.
38. Boehm G, Fanaro S, Jelinek J, et al. (2003) Prebiotic concept for infant nutrition. Acta Paediatr Suppl 91, 64-67.
39. Han Y, Chang EY, Kim J, et al. (2011) Association of infant feeding practices in the general population with infant growth and stool characteristics. Nutr Res Pract 5, 308-312.
40. Windey K, De Preter V & Verbeke K (2012) Relevance of protein fermentation to gut health. Mol Nutr Food Res 56, 184-196.
41. Koleva PT, Bridgman SL & Kozyrskyj AL (2015) The infant gut microbiome: evidence for obesity risk and dietary intervention. Nutrients 7, 2237-2260.
42. Saari A, Virta LJ, Sankilampi U, et al. (2015) Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics 135, 617-626.
43. Vandenplas Y, Huaser B, Blecker U, et al. (1993) The nutritional value of a whey hydrolysate formula compared with a whey-predominant formula in healthy infants. J Pediatr Gastroenterol Nutr 17, 92-96.
44. Agostoni C, Grandi F, Scaglioni S, et al. (2000) Growth pattern of breastfed and nonbreastfed infants with atopic dermatitis in the first year of life. Pediatrics 106, e73.
45. Miraglia Del Guidice M, DAuria E, Peroni D, et al. (2015) Flavor, relative palatability and components of cows milk hydrolysed formulas and amino acid-based formula. Italian J Pediatr 41, 42-49.